Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.
Publication
, Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
April 2004
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
April 2004
Volume
17
Issue
2
Start / End Page
157 / 159
Related Subject Headings
- Protein Binding
- Oligonucleotides
- Humans
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2004). Protein-binding oligonucleotides: the next frontier in antithrombotic therapy. Journal of Thrombosis and Thrombolysis, 17(2), 157–159. https://doi.org/10.1023/b:thro.0000037673.15166.38
Becker, Richard C. “Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.” Journal of Thrombosis and Thrombolysis 17, no. 2 (April 2004): 157–59. https://doi.org/10.1023/b:thro.0000037673.15166.38.
Becker RC. Protein-binding oligonucleotides: the next frontier in antithrombotic therapy. Journal of thrombosis and thrombolysis. 2004 Apr;17(2):157–9.
Becker, Richard C. “Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.” Journal of Thrombosis and Thrombolysis, vol. 17, no. 2, Apr. 2004, pp. 157–59. Epmc, doi:10.1023/b:thro.0000037673.15166.38.
Becker RC. Protein-binding oligonucleotides: the next frontier in antithrombotic therapy. Journal of thrombosis and thrombolysis. 2004 Apr;17(2):157–159.
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
April 2004
Volume
17
Issue
2
Start / End Page
157 / 159
Related Subject Headings
- Protein Binding
- Oligonucleotides
- Humans
- Fibrinolytic Agents
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences